Prostate Cancer - Results from #28420

Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D(3) induced cell growth inhibition in prostate cancer - Abstract March 17, 2011

Phase II evaluation of early oral estramustine, oral etoposide, and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group S0032 - Abstract March 17, 2011

Prostate cancer gene 3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy - Abstract March 16, 2011

Industry-based retrospective cohort study of the risk of prostate cancer among rotating-shift workers - Abstract March 16, 2011

Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry - Abstract March 16, 2011

Inapparent tumor on endorectal multimodality magnetic resonance imaging of prostate: Should we perform a biopsy? - Abstract March 16, 2011

Focal therapy for localized prostate cancer: A phase I/II trial - Abstract March 16, 2011

Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery - Abstract March 16, 2011

Urinary PCA3 score predicts prostate cancer multifocality - Abstract March 16, 2011

A model to predict prostate cancer after atypical findings in initial prostate needle biopsy - Abstract March 16, 2011

Physician assessment of pretreatment functional status: A process-outcomes link - Abstract March 16, 2011

Editor's Commentary - Spirituality and end-of-life care in disadvantaged men dying of prostate cancer March 16, 2011

Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era - Abstract March 15, 2011

Safety profile of robot-assisted radical prostatectomy: A standardized report of complications in 3317 patients - Abstract March 15, 2011

Prostate cancer staging and grading at radical prostatectomy over time - Abstract March 15, 2011

Patients with localised prostate cancer (t1 - t2) show improved overall long-term survival compared to the normal population - Abstract March 15, 2011

Hormone depletion-insensitivity of prostate cancer cells is supported by the AR without binding to classical response elements - Abstract March 15, 2011

Cone beam CT pre- and post-daily treatment for assessing geometrical and dosimetric intrafraction variability during radiotherapy of prostate cancer - Abstract March 15, 2011

Sipuleucel-T: Harbinger of a new age of therapeutics for prostate cancer - Abstract March 15, 2011

Research shows rapid adoption of newer, more expensive prostate cancer treatments March 15, 2011

Page 1422 of 1435